in Lower Extremity Surgery
Backed by more than 30 years in the ever-expanding field of medicine, DT MedTech, LLC, a powerhouse in the medical device industry, is dedicated to providing innovative surgical solutions for lower extremity surgeons with state-of-the art devices designed to ensure better patient outcomes.
With the rapidly evolving Total Ankle Replacement market, DT MedTech was originally formed to exploit the intellectual property of European Foot Platform S. A. R. L. (EFP) and Dr. Beat Hintermann to improve patient care with the highest quality products. Dr. Beat Hintermann, Chairman of the Clinic for Orthopaedics and Traumatology at Kantonsspital Baselland in Liestal, Switzerland, developed the Hintermann Series H3™ non-constrained Total Ankle Replacement system more than 20 years ago and has seen continued success in the global marketplace. In June 2019, the Hintermann Series H3 TAR system received FDA PMA approval for the use of the product to replace the ankle joint in primary surgeries.
In November 2017, DT MedTech and Dr. Hintermann introduced the Hintermann Series H2® Total Ankle Replacement system. This innovative new implant is a two-component, semi-constrained Total Ankle Replacement system that is indicated for use as non-cemented implant outside of the US and as a cemented implant within the US. In addition, it may be used for primary replacement or revision surgery.
Now with the Hintermann Series Total Ankle Replacement Systems, both US and outside the US (OUS) surgeons will have an opportunity, using a single instrument set, to offer a full solution to their patients using the H2 and H3 to perform primary (H2 and H3), revision (H2), or take-down TARs (H2).